The burden of moderate-to-severe genital psoriasis: Patients' perspective on symptoms

被引：0
|
作者：
Ryan, Caitriona [1 ]
Meeuwis, Kim [1 ]
Bleakman, Alison Potts [2 ]
Naegeli, April [2 ]
Poon, Jiat Ling [2 ]
Hollister, Kristin [2 ]
机构：
[1] Baylor Univ, Med Ctr, Waco, TX 76798 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
4548
引用
收藏
页码：AB249 / AB249
页数：1
相关论文
共 50 条
  • [41] Use of systemic and biological therapy in patients with moderate-to-severe psoriasis
    Liljendahl, Mie S.
    Loft, Nikolai
    Nguyen, Tri-Long
    Skov, Lone
    Egeberg, Alexander
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 49 (01) : 35 - 41
  • [42] Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics
    Offidani, Annamaria
    Radi, Giulia
    Bianchi, Luca
    Cannavo, Serafinella Patrizia
    Conti, Andrea
    Gesuita, Rosaria
    Salaffi, Fausto
    Talamonti, Marina
    Campanati, Anna
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (04) : 493 - 498
  • [43] Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients
    Libon, Florence
    Lebas, Eve
    De Schaetzen, Virginie
    Sabatiello, Murielle
    De Schepper, Sofie
    Nikkels, Arjen F.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 947 - 955
  • [44] Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal
    Tsakok, T.
    Jabbar-Lopez, Z. K.
    Smith, C. H.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 50 - 53
  • [45] Clinical signs of epithelial surface disruption impact pain and sexual Health in Patients with moderate-to-severe genital psoriasis
    Schloebe, A.
    [J]. EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E50 - E51
  • [46] Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics
    Annamaria Offidani
    Giulia Radi
    Luca Bianchi
    Serafinella Patrizia Cannavò
    Andrea Conti
    Rosaria Gesuita
    Fausto Salaffi
    Marina Talamonti
    Anna Campanati
    [J]. European Journal of Dermatology, 2021, 31 : 493 - 498
  • [47] Clinical signs of epithelial surface disruption impact pain and sexual health in patients with moderate-to-severe genital psoriasis
    Lambert, J.
    Ghislain, P. -D.
    Merola, J.
    Potts-Bleakman, A.
    Brnabic, A. J. M.
    Burge, R.
    Riedl, E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 : 36 - 36
  • [48] Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective
    de la Brassinne, Michel
    Ghislain, Pierre-Dominique
    Lambert, Jo L. W.
    Lambert, Julien
    Segaert, Siegfried
    Willaert, Fabienne
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (02) : 128 - 133
  • [49] Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective
    Igarashi, Atsuyuki
    Igarashi, Ataru
    Graham, Christopher N.
    Gilloteau, Isabelle
    Tani, Yumiko
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (01) : 7 - 15
  • [50] INCREMENTAL BURDEN OF CARDIOVASCULAR COMORBIDITY OR PSORIATIC ARTHRITIS AMONG INDIVIDUALS WITH MODERATE-TO-SEVERE PSORIASIS
    Augustin, M.
    Tian, H.
    Gilloteau, I
    Mollon, P.
    Vietri, J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A126 - A126
12345